Literature DB >> 34037853

Dental calculus-a reservoir for detection of past SARS-CoV-2 infection.

Federico Berton1, Katia Rupel2, Fiorella Florian3, Matteo Biasotto1, Alberto Pallavicini3, Roberto Di Lenarda1.   

Abstract

Entities:  

Keywords:  COVID-19; Dental calculus; Nasopharyngeal swabs; SARS-CoV-2; Serological testing

Mesh:

Year:  2021        PMID: 34037853      PMCID: PMC8152705          DOI: 10.1007/s00784-021-04001-8

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


× No keyword cloud information.
Dear Sir/Madame, The SARS-CoV-2 outbreak left all the scientific and medical community with tremendous doubts and difficulties in managing both symptomatic and asymptomatic patients, especially in case of seronegativity [1, 2]. In fact, in patients with mild symptoms, detectable IgG may not develop or progressively decrease [3]. The present letter aims to highlight an interesting finding, never mentioned before, that may help clinicians and epidemiologists in detecting previous SARS-CoV-2 infection. Learning from archaeological studies [4], we hypothesized that dental calculus, a mineralized oral plaque biofilm that contains biomolecules such as nucleic acids, could have preserved SARS-CoV-2 RNA after infection, regardless of the development and severity of symptoms. Here, we present the results from a pilot study including five individuals with previous diagnosis of SARS-CoV-2 infection obtained by nasopharyngeal swab testing and subsequently healed within two months prior the study (POS), two individuals contact with a positive who developed mild symptoms and were negative at nasopharyngeal swab testing (SUSP), and five healthy individuals who denied contacts with positive subjects and had negative nasopharyngeal swabs (CTRL). All subjects underwent dental calculus sampling performed with sterile curettes. Samples were analyzed performing real-time reverse transcription polymerase chain reaction assays after nucleic acid extraction and amplification. The RdRp Institut Pasteur IP2 assay was used, as previous studies demonstrated its high sensitivity and specificity [5]. The results showed that SARS-CoV-2 RNA was detected in all POS subjects, in the two SUSP subjects, and one among CTRL subjects. Ct values are reported in Table 1. Furthermore, one of the POS subjects resulted negative at a serologic assay while the other four subjects developed specific IgG antibodies. Samples were further analyzed using the CDC N1 assay, confirming the presence of SARS-CoV-2 RNA in one POS subject. The presence of SARS-CoV-2 RNA was confirmed by genomic sequencing of the amplicons obtained with the RdRp Institut Pasteur IP2 assay. Sanger sequencing was run at Eurofins Genomics facilities.
Table 1

Characteristics of the subjects included in the pilot study

Subject numberGroupSymptomsNasopharyngeal swabSerological testingCt values (N1)Ct values (IP2)
1SUSPMildNegativeNegativeND35,78
2SUSPMildNegativeNegativeND35,71
3POSPresentPositivePositiveND37,28
4POSPresentPositivePositiveND41,07
5POSPresentPositivePositiveND33,37
6POSPresentPositiveNegative36,1934,73
7POSPresentPositivePositiveND32,69
8CTRLAbsentNegativeNegativeND37,25
9CTRLAbsentNegativeNegativeNDND
10CTRLAbsentNegativeNegativeNDND
11CTRLAbsentNegativeNegativeNDND
12CTRLAbsentNegativeNegativeNDND

POS subjects with previous diagnosis of SARS-CoV-2 infection and healed at the time of sampling, SUSP individual contact with a subject with diagnosis of SARS-CoV-2 infection who developed mild symptoms, CTRL subjects who denied both contacts with positive subjects and symptoms, N1 primers and probes for PCR amplification of the N gene 28287–28358* (US Centers for Disease Control and Prevention CDC, USA), IP2 primers and probes for PCR amplification of the RdRp gene 12690–12797*, (Institute Pasteur, Paris), ND not detectable

Nucleotide numbering based on Wuhan-Hu-1 GenBank MN908997

Characteristics of the subjects included in the pilot study POS subjects with previous diagnosis of SARS-CoV-2 infection and healed at the time of sampling, SUSP individual contact with a subject with diagnosis of SARS-CoV-2 infection who developed mild symptoms, CTRL subjects who denied both contacts with positive subjects and symptoms, N1 primers and probes for PCR amplification of the N gene 28287–28358* (US Centers for Disease Control and Prevention CDC, USA), IP2 primers and probes for PCR amplification of the RdRp gene 12690–12797*, (Institute Pasteur, Paris), ND not detectable Nucleotide numbering based on Wuhan-Hu-1 GenBank MN908997 Dental calculus has been previously analyzed, mostly for microbiome definition in archaeological human samples and serving as milieu for the preservation of genomic information. Similarly, dental calculus may be helpful to detect SARS-CoV-2 traces in previously infected and possibly also in asymptomatic or mild symptomatic patients that may not develop detectable antibodies, therefore lacking a method to confirm the occurred infection. Further studies are needed to define method’s reliability, cost/effectiveness, and suitability for large-scale epidemiological studies or post-mortem analysis. Although our study has some limitations due to the small number of samples, we believe that its interest resides in the fact that it is the first describing the presence of SARS-CoV-2 RNA in dental calculus.
  2 in total

1.  Pathogens and host immunity in the ancient human oral cavity.

Authors:  Christina Warinner; João F Matias Rodrigues; Rounak Vyas; Christian Trachsel; Natallia Shved; Jonas Grossmann; Anita Radini; Y Hancock; Raul Y Tito; Sarah Fiddyment; Camilla Speller; Jessica Hendy; Sophy Charlton; Hans Ulrich Luder; Domingo C Salazar-García; Elisabeth Eppler; Roger Seiler; Lars H Hansen; José Alfredo Samaniego Castruita; Simon Barkow-Oesterreicher; Kai Yik Teoh; Christian D Kelstrup; Jesper V Olsen; Paolo Nanni; Toshihisa Kawai; Eske Willerslev; Christian von Mering; Cecil M Lewis; Matthew J Collins; M Thomas P Gilbert; Frank Rühli; Enrico Cappellini
Journal:  Nat Genet       Date:  2014-02-23       Impact factor: 38.330

2.  Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.

Authors:  Emelie Marklund; Susannah Leach; Hannes Axelsson; Kristina Nyström; Heléne Norder; Mats Bemark; Davide Angeletti; Anna Lundgren; Staffan Nilsson; Lars-Magnus Andersson; Aylin Yilmaz; Magnus Lindh; Jan-Åke Liljeqvist; Magnus Gisslén
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

  2 in total
  3 in total

Review 1.  Pros and Cons of CAD/CAM Technology for Infection Prevention in Dental Settings during COVID-19 Outbreak.

Authors:  Livia Barenghi; Alberto Barenghi; Umberto Garagiola; Alberto Di Blasio; Aldo Bruno Giannì; Francesco Spadari
Journal:  Sensors (Basel)       Date:  2021-12-22       Impact factor: 3.576

2.  SARS CoV-2 load in periodontal disease.

Authors:  Vaibhav Sahni
Journal:  J Am Dent Assoc       Date:  2021-11-11       Impact factor: 3.634

3.  Post-Operative Bleeding Complications in a Periodontitis Patient Testing Positive for COVID-19.

Authors:  Georgios Loukas; Madeline X F Kosho; Spiros Paraskevas; Bruno G Loos
Journal:  Dent J (Basel)       Date:  2022-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.